CVSA today
$118.17-$0.83 (-0.70%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourBearish
15 minDescending Triangle
5 minConsolidating
Daily trend turns down below $116.59
Key levels
Resistance$133.78
Resistance$125.02
Support$116.59
Support$107.45
Latest news & SEC filings
EarningsCovista posts fiscal Q1 2027 results, lifts outlook, CFO to retire
EarningsCovista Discusses First-Quarter Fiscal 2027 Results on Conference Call
GuidanceCovista lifts FY2027 adjusted EPS outlook to $9.00-$9.20 and sales view to $2.060B-$2.095B
EarningsCovista Q1 profit tops forecast at $2.19 per share; revenue $511.534M
All CVSA news →About Covista
Covista is a healthcare education provider whose schools include Chamberlain University, Walden University, and three Caribbean-based institutions focused on human and veterinary medicine. Its academic offerings span nursing, medical, veterinary, counseling, business, education, public health, and social work credentials at the undergraduate through doctoral levels. Instruction takes place at U.S. and Caribbean campuses and online, with clinical placements arranged through partner sites in North America, the Caribbean, and Europe.
Based on the company's 10-K filed Aug 6, 2026.
NYSE · Communication Services
Covista Inc. (CVSA)
What Is the Price Target for CVSA?
SEPT Low Target
$140.00
SEPT Mid Target
$142.50
SEPT High Target
$145.00
Analyst Consensus
$142.50
Is CVSA a Buy or Sell Right Now?
Thesis
- •Revenue growing 9.3% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CVSA.
Start Free Trial →Is CVSA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$154.25
36
Moat Score
NONE
5/9
Piotroski Score
4.2
Altman Z-Score
What Is Smart Money Doing with CVSA?
Insider Signal
NEUTRAL
4 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Betz Michael | officer | Sale | 838 | $100K | Nov 12, 2026 |
| Vandenbosch Betty M. | director | Sale | 390 | $46K | Nov 12, 2026 |
| Storms Leslie | director | Sale | 85 | $10K | Nov 12, 2026 |
| Phelan Robert J. | officer | Sale | 629 | $75K | Nov 12, 2026 |
| Phelan Kenneth J | director | Sale | 363 | $43K | Nov 12, 2026 |
| Noel Megan | officer | Sale | 329 | $39K | Nov 12, 2026 |
| MALAFRONTE MICHAEL W | director | Sale | 487 | $58K | Nov 12, 2026 |
| Liles Scott | officer | Sale | 350 | $42K | Nov 12, 2026 |
| Krehbiel William V | director | Sale | 390 | $46K | Nov 12, 2026 |
| Kiser Georgette D. | director | Sale | 391 | $47K | Nov 12, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CVSA Growth Story
Revenue YoY
9.3%
3yr Revenue CAGR
10.4%
EPS Growth YoY
13.92%
FCF Growth YoY
36.6%
Revenue Trend
STABLE
Dark Pool Trades for CVSA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CVSA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:46 | $118.17 | 4,079 | $$482K | SELL |
| 21:00:46 | $118.17 | 15,606 | $$1.8M | SELL |
| 20:54:14 | $118.42 | 1,200 | $$142K | BUY |
| 15:14:25 | $118.92 | 1,600 | $$190K | MIDPOINT |
| 15:14:16 | $118.92 | 1,400 | $$166K | SELL |
5 dark pool trades shown · $$2.8M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Covista Inc. (CVSA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CVSA — frequently asked questions
What is CVSA stock price today?
Covista Inc. (CVSA) is at $118.17, down 0.70% (-$0.83) at the Nov 13, 2026 close.
Why is CVSA stock moving today?
Latest CVSA news — Oct 29, 2026: Covista posts fiscal Q1 2027 results, lifts outlook, CFO to retire · Oct 29, 2026: Covista Discusses First-Quarter Fiscal 2027 Results on Conference Call
What is the CVSA price target?
The average analyst price target for CVSA is $142.50, ranging from $140 to $145, based on 2 analysts. Latest: BMO Capital maintains on Oct 5, 2026.
What do analysts rate CVSA?
Analyst ratings for CVSA: 0 Buy, 2 Hold, 1 Sell — consensus Hold.
Did CVSA beat earnings?
CVSA last reported on Oct 29, 2026: EPS $2.19 vs $1.83 expected — a beat of 19.7%.
What is CVSA's P/E ratio?
CVSA trades at a P/E of 17.0 vs a Communication Services average of 14.3.
Does CVSA pay a dividend?
CVSA does not currently pay a dividend.
How much debt does CVSA have?
Covista Inc. reported $500M of debt and $222M of cash (Sep 30, 2026).
What are CVSA support and resistance levels?
Support: $116.59, $107.45, $99.01. Resistance: $125.02, $133.78, $142.13.
What are insiders doing with CVSA?
Insider activity: NEUTRAL, 4 buys and 9 sells in the last 90 days.
What is the latest news on CVSA?
Oct 29, 2026: Covista posts fiscal Q1 2027 results, lifts outlook, CFO to retire · Oct 29, 2026: Covista Discusses First-Quarter Fiscal 2027 Results on Conference Call · Oct 29, 2026: Covista lifts FY2027 adjusted EPS outlook to $9.00-$9.20 and sales view to $2.060B-$2.095B